Have a personal or library account? Click to login
Differential S-phase progression after irradiation of p53 functional versus non-functional tumour cells Cover

Differential S-phase progression after irradiation of p53 functional versus non-functional tumour cells

Open Access
|Nov 2014

References

  1. 1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-11.
  2. 2. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491-5.10.1073/pnas.89.16.7491
  3. 3. Howard A, Pelc SR. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity 1953; 6: 261-73.
  4. 4. Little JB. Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature 1968; 218: 1064-5.10.1038/2181064a0
  5. 5. Cuddihy AR, Bristow RG. The p53 protein family and radiation sensitivity: Yes or no? Cancer Met Rev 2004; 23: 237-57.
  6. 6. Zölzer F, Streffer C. Quiescence in S-phase and G1 arrest induced by irradiation and/or hyperthermia in six human tumour cell lines of different p53 status. Int J Radiat Biol 2000; 76: 717-25.10.1080/095530000138394
  7. 7. Terasima T, Tolmach LJ. Variations in several responses of HeLa cells to xirradiation during the division cycle. Biophys J 1963; 3: 11-33.10.1016/S0006-3495(63)86801-0
  8. 8. Zölzer F, Jagetia G, Streffer C. G2-block after irradiation of cells with different p53 status. Strahlen Onkol, June 14 2014. [Epub ahead of print]. doi 10.1007/s00066-014-0690-510.1007/s00066-014-0690-5
  9. 9. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995; 92: 8493-7.10.1073/pnas.92.18.8493
  10. 10. Stewart N, Hicks GG, Paraskevas F, Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene 1995; 10: 109-15.
  11. 11. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497-501.10.1126/science.282.5393.1497
  12. 12. Solberg Landsverk K, Patzke S, Rein ID, Stokke C, Lyng H, De Angelis PM, Stokke T. Three independent mechanisms for arrest in G2 after ionizing radiation. Cell Cycle 2011; 10: 819-29.10.4161/cc.10.5.14968
  13. 13. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001; 20: 1803-15.10.1038/sj.onc.1204252
  14. 14. Stark GR, Taylor WR. Control of the G2/M transition. Mol Biotech 2006; 32: 227-48.10.1385/MB:32:3:227
  15. 15. Busse PM, Bose SK, Jones RW, Tolmach LJ. The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray-induced killing during G2 arrest. Radiat Res 1978; 76: 292-307.10.2307/3574780
  16. 16. Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, et al. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res 1995; 55: 1643-8.10.1016/0360-3016(95)97825-L
  17. 17. Musk SR. Reduction of radiation-induced cell cycle blocks by caffeine does not necessarily lead to increased cell killing. Radiat Res 1991; 125: 262-6.10.2307/3578108
  18. 18. Schwartz JL, Cowan J, Grdina DJ, Weichselbaum RR. Attenuation of G2- phase cell cycle checkpoint control is associated with increased frequencies of unrejoined chromosome breaks in human tumor cells. Radiat Res 1996; 146: 139-43.10.2307/3579585
  19. 19. Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003; 22: 5834-47.10.1038/sj.onc.1206682
  20. 20. Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci USA 1980; 77: 7315-710.1073/pnas.77.12.7315
  21. 21. Larner JM, Lee H, Hamlin JL. S phase damage sensing checkpoints in mammalian cells. Cancer Surv 1997; 29: 25-45.
  22. 22. Morgan SE, Lovly C, Pandita TK, Shiloh Y, Kastan MB. Fragments of ATM which have dominant-negative or complementing activity. Mol Cell Biol 1997; 17: 2020-9.10.1128/MCB.17.4.2020
  23. 23. Fei P, El-Deiry WS. P53 and radiation responses. Oncogene 2003; 22: 5774-83.10.1038/sj.onc.1206677
  24. 24. Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nature Rev Mol Cell Biol 2004; 5: 792-804.10.1038/nrm1493
  25. 25. Liu WF, Yu SS, Chen GJ, Li YZ. DNA damage checkpoint, damage repair, and genome stability. Acta Gen Sin 2006; 33: 381-90.10.1016/S0379-4172(06)60064-4
  26. 26. Lee AY, Chiba T, Truong LN, Cheng AN, Do J, Cho MJ, et al. Dbf4 is direct downstream target of ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) protein to regulate intra-S-phase checkpoint. J Biol Chem 2012; 287: 2531-43.10.1074/jbc.M111.291104
  27. 27. Falck J, Petrini JH, Williams BR, Lukas J, Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Gen 2002; 30, 290-4.10.1038/ng845
  28. 28. Willis N, Rhind N. Regulation of DNA replication by the S-phase DNA damage checkpoint. Cell Div 2009; 4: 13.10.1186/1747-1028-4-13
  29. 29. Dai Y, Grant S. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res 2010; 16: 376-83.10.1158/1078-0432.CCR-09-1029
  30. 30. Yazdi PT, Wang Y, Zhao S, Patel N, Lee EY, Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev 2002; 16: 571-82.10.1101/gad.970702
  31. 31. Luo H, Li Y, Mu JJ, Zhang J, Tonaka T, Hamamori Y, et al. Regulation of intra-S phase checkpoint by ionizing radiation (IR)-dependent and IR-independent phosphorylation of SMC3. J Biol Chem 2008; 283: 19176-83.10.1074/jbc.M802299200
  32. 32. Zhou XY, Wang X, Hu B, Guan J, Iliakis G, Wang Y. An ATM-independent S-phase checkpoint response involves CHK1 pathway. Cancer Res 2002; 62: 1598-603.
  33. 33. Sørensen CS, Syljuåsen RG, Falck J, Schroeder T, Rönnstrand L, Khanna KK, Zhou BB, Bartek J, Lukas J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003; 3: 247-58.10.1016/S1535-6108(03)00048-5
  34. 34. Cho YJ, Liang P. Killin is a p53-regulated nuclear inhibitor of DNA synthesis. Proc Natl Acad Sci USA 2008; 105: 5396-401.10.1073/pnas.0705410105229108018385383
  35. 35. Cho YJ, Liang P. S-phase-coupled apoptosis in tumor suppression. Cell Mol Life Sci 2008; 68: 1883-96.
  36. 36. Demidova AR, Aau MY, Zhuang L, Yu Q. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control. J Biol Chem 2009; 284: 4132-9.10.1074/jbc.M80811820019060337
  37. 37. Vigneron A, Cherier J, Barré B, Gamelin E, Coqueret O. The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression. J Biol Chem 2006; 281: 34742-50.10.1074/jbc.M60249220016923815
  38. 38. Zhu Y, Alvarez C, Doll R, Kurata H, Schebye XM, Parry D, Lees E. Intra-S-phase checkpoint activation by direct CDK2 inhibition. Mol Cell Biol 2004; 24: 6268-77.10.1128/MCB.24.14.6268-6277.2004
  39. 39. Weininger J, Guichard M, Joly AM, Malaise EP, Lachet B. Radiosensitivity and growth parameters in vitro of three human melanoma cell strains. Int J Radiat Biol 1978; 34: 285-90.
  40. 40. Fogh J, Bean MA, Brüggen J, Fogh H, Fogh JM, Hammar SP, et al. Comparison of a human tumor cell line before and after growth in the nude mouse. In: Fogh J, Giovanella B, editors. The nude mouse in experimental and clinical research. New York: Academic Press; 1978. p. 215-45.
  41. 41. Zölzer F, Hillebrandt S, Streffer C. Radiation induced G1-block and p53 status in six human cell lines. Radiother Oncol 1995; 37: 20-8.10.1016/0167-8140(95)01618-Q
  42. 42. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, et al. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 1994; 4: 35-45.10.1097/00008390-199402000-00006
  43. 43. Böhnke A, Westphal F, Schmidt A, El-Awady RA, Dahm-Daphi J. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells. Int J Radiat Biol 2004; 80: 53-63.10.1080/09553000310001642902
  44. 44. Binder AB, Serafin AM, Bohm LJ. Abrogation of G(2)/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumor cells. Radiat Res 2000; 154: 640-9.10.1667/0033-7587(2000)154[0640:AOGMPB]2.0.CO;2
  45. 45. Stuschke M, Budach V, Sack H. Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumour differentiation. Int J Radiat Oncol Biol Phys 1993; 27: 627-36.10.1016/0360-3016(93)90389-D
  46. 46. Wurm R, Ketel B, Schröder G, Sinn B, Schlenger L, Wolf G, et al. Strahlenempfindlichkeit nach kombination von bestrahlung und koffein. Strahlenther Onkol 1997; 173: 614.
  47. 47. Zölzer F, Uma Devi P, Streffer C. Determination of potential doubling times in human melanoma cell cultures subjected to irradiation and/or hyperthermia by flow cytometry. Radiat Res 1994; 138: 451-9.10.2307/3578695
  48. 48. Zölzer F, Streffer C, Pelzer T. Induction of quiescent S-phase cells by irradiation and/or hyperthermia. I. Time and dose dependence. Int J Radiat Biol 1993; 63: 69-76.10.1080/09553009314550091
  49. 49. Begg AC, Moonen L, Hofland I, Dessing M, Bartelink H. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations. Radiother Oncol 1988; 11: 337-47.10.1016/0167-8140(88)90205-8
  50. 50. Zölzer F, Streffer C. G2-phase delays after irradiation and/or heat treatment as assessed by two-parameter flow cytometry. Radiat Res 2001; 155: 50-6.10.1667/0033-7587(2001)155[0050:GPDAIA]2.0.CO;2
  51. 51. Zhou J, Prives C. Replication of damaged DNA in vitro is blocked by p53. Nucl Acid Res 2003; 31: 3881-92.10.1093/nar/gkg46816598212853603
  52. 52. Mirzayans R, Aubin RA, Bosnich W, Blattner WA, Paterson MC. Abnormal pattern of post-γ-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome. Br J Cancer 1995; 71: 1221-30. 10.1038/bjc.1995.23720338547779715
DOI: https://doi.org/10.2478/raon-2014-0032 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 354 - 360
Submitted on: Apr 24, 2014
|
Accepted on: Jul 24, 2014
|
Published on: Nov 5, 2014
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2014 Friedo Zölzer, Tamare Mußfeldt, Christian Streffer, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.